说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 双表型急性白血病
1)  biphenotypic acute leukemia
双表型急性白血病
1.
The aim of this study was to investigate the clinical, pathological and biological features of biphenotypic acute leukemia.
本研究通过实例分析双表型急性白血病的临床、病理和生物学特征,用骨髓细胞涂片观察肿瘤细胞的形态,流式细胞术和免疫组织化学检测肿瘤细胞的免疫表型,常规染色体分析和多重巢式RT-PCR检测染色体畸变。
2)  Criteria for diagnosis
急性双表型白血病
3)  acute Leukemia biphenotypic
急性白血病双表型
4)  Acute leukemia/classification
急性白血病/分型
5)  acute leukemia
急性白血病
1.
Comparing the level of serum ET and observing the therapeutic effect in different types of TCM in patients with acute leukemia;
不同中医证型急性白血病患者血浆内皮素含量比较及临床疗效观察
2.
One case report of spontaneous remission of adult acute leukemia and literature review;
成人急性白血病自然缓解1例报道并文献复习
3.
Relation between the expression of VEGF,MMP-2,MMP-9 of bone marrow cells and acute leukemia;
VEGF、MMP-2及MMP-9在骨髓细胞中的表达及其与急性白血病的关系
6)  Acute leukaemia
急性白血病
1.
To evaluate the expression of cyclin G2 mRNA in patients with acute leukaemia (AL) and its clinical value, the expression of cyclin G2,G1 and P53 mRNA in the bone marrow from 74 AL patients and 10 normal individuals as control were detected with reverse transcription polymerase chain reaction (RT-PCR).
为了探讨急性白血病(AL)患者中细胞周期蛋白G2(cyclin G2)的mRNA表达及其临床意义,采用逆转录 聚合酶链反应(RT-PCR)法检测74例急性白血病患者及10例正常人骨髓细胞中的cyclin G2、G1和P53的mRNA 表达,对cyclin G2的阳性扩增产物进行序列分析。
2.
Five cases of acute leukaemia patients with received nonmyeloablative allogeneic peripheral blood stem cells transplantation(NAPBSCT) from HLA identical siblings using a nonmyeloablative conditioning regimen.
采用非清髓预处理 (环胞霉素A、环磷酰胺、阿糖胞苷及CD3单克隆抗体或抗淋巴细胞球蛋白 )的异基因外周造血干细胞移植治疗急性白血病 5例。
3.
Methods:The immunological fluorescent double-marker and the flowcytometer was used to detect the line-related antigen on acute leukaemia cell, espically detect different line-related antigen to express on the same cell simultaneously o.
方法:采用免疫荧光双标记技术配合流式细胞术检测急性白血病细胞的系列相关抗原双标记,特别是检测不同细胞系相关抗原在同一细胞上同时表达,或/和CD34 同时表达,观察其在化疗前后数量的变化,与形态学判断疗效结合起来并加以比较,以观察其临床意义。
补充资料:双表
1.华表。通常成对﹐故称。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条